ZEPP HEALTH CORP-ADR
ZEPPNYSE🏆 #3405 by market capUS Equity
$976.52▲ $48.73 (+4.99%)
Simulated price1h—
24h▲ 5.0%
7d▲ 20501.7%
14d▲ 21795.1%
30d▲ 18084.7%
1y▲ 2790.4%
🏦Market Cap
$65M
Small Cap
📈Revenue Growth (YoY)
-11.9%
Declining
📊Gross Margin
39.0%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
0.3x
Cheap
Otter Score
62
Fair
Trading Snapshot
- Day Range
- $968.27 – $983.03
- 52-Week Range
- $3.85 – $61.85
- Volume
- $4.18B
- Avg Volume
- $3.58B
- Shares Outstanding
- 234.9M
- Next Earnings
- Oct 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $196M
- Last Q Revenue
- $48M
- P/E Ratio
- —
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-0.15
- Dividend Yield
- —
Why Investors Own ZEPP
- ✓High-growth profile — revenue up +6.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 77% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$196M▲ +7.3% YoY
Gross Margin (TTM)
76.6%▲ +2.5% YoY
Operating Income (TTM)
$18M▲ +7.3% YoY
Free Cash Flow (TTM)
$28M▲ +7.3% YoY
About ZEPP HEALTH CORP-ADR
A company profile for ZEPP HEALTH CORP-ADR isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
62/100
Analyst Price Target
ⓘAverage Target
$1,160.83
▲ +18.9% Upside
High Target$1,278.66
Low Target$1,005.82
Based on 39 analysts
Latest News & Updates
🚀
CNBC·2h ago
ZEPP HEALTH CORP-ADR tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift ZEPP price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
ZEPP HEALTH CORP-ADR announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.